Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?

though the forward P/E of 20x suggests normalization as earnings grow. Compared to peer Johnson & Johnson's 2.16% dividend yield and 46.6% payout ratio, Abbott's 63.8% payout ratio shows less cushion but remains sustainable.The stock's 12.2% decline over the past year contrasts with its dividend growth, creating a higher yield entry point. Institutional investors maintain 81.7% ownership, suggesting confidence in the long-term story despite near-term challenges.## The Verdict: Solid Dividend with Manageable ...